Professional Documents
Culture Documents
Viral Meningitis
INTRODUCTION
OVERVIEW
EPIDEMIOLOGY
PATHOGENESIS
ETIOLOGY
CLINICAL FEATURES
DIAGNOSIS
TREATMENT
PREVENTION
TAKE HOME POINTS
EPIDEMIOLOGY
PATHOGENESIS
PRIMARY VIRAL INFECTION
GI mucosa
Respiratory
mucosa
Primary Viremia
Onset of illness
Organ seeding
Secondary viremia
Reach CNS
Multiplication
CONT
Transendothelial passage of the virus occurs in vessels of the
choroid plexus, meninges, or cerebrum: Bridging the endothelium within migrating leukocytes
Pinocytosis or colloidal transport
Breaking through damaged endothelium
Direct infection of endothelial cells
ETIOLOGY
Enterovirus
( most common)
Human parechoviruses
Herpesviruses,
Arboviruses
lymphocytic choriomeningitis virus
Rabies
Influenza
CLINICAL FEATURES
Presence
CONT
Vary
CONT
DIAGNOSING
History: The presence of classic symptoms
Symptoms of encephalitis
Symptoms associated with specific viruses
Preceding illness
Immunization history
Outbreaks of human or animal disease
CONT
Examination
Signs of meningeal inflammation
(nuchal rigidity, Kernig and
Brudzinski signs)
Assessment of mental status
(Glasgow coma scale) and presence
of focal neurologic signs
Findings associated with EV infection
Findings associated with other
potential causes of viral meningitis
CONT
Imaging
Computed
CONT
Laboratory Test
Blood test
-Blood culture, PT, PTT, CBC, Electrolyte, BUN,
urea , creatinine
CSF studies
-CSF WBC of <500 cells/microL with a
mononuclear predominance
-Normal CSF glucose
-CSF protein <100 mg/dL
-Negative CSF Gram stain
-Enterovirus disease in the Improvement in
symptoms following lumbar puncture
DIFFERENTIAL
DIAGNOSIS
Bacterial meningitis
-The Bacterial Meningitis Score (BMS) sensitivity
and specificity 99.3 percent (95% CI 98.7-99.7
percent) and 62.1 percent (60.5 to 63.7 percent),
respectively
Positive CSF Gram stain
CSF absolute neutrophil count 1000 cells/microL
CSF protein 80 mg/dL
Peripheral blood ANC 10,000 cells/microL
History of seizure before or at the time of
presentation
TREATMENT
Hospitalization
The
PROGNOSIS
PREVENTION
Hygiene
Vaccine
Personal protection
Infection Control
CONT
MATUR NUWUN
REFERENCE
Cecilia